MiR-150 explained

miR-150
Symbol:miR-150
Altsymbols:MIR150
Rfam:RF00767
Mirbase:MI0000479
Mirbase Family:MIPF0000197
Rna Type:miRNA
Tax Domain:Mammalia
Go:0035195
So:0001244
Entrezgene:406942
Hgncid:31537
Omim:610566
Refseq:NR_029703
Chromosome:19
Arm:q
Band:13.33

miR-150 is a family of microRNA precursors found in mammals, including humans. The ~22 nucleotide mature miRNA sequence is excised from the precursor hairpin by the enzyme Dicer.[1] This sequence then associates with RISC which effects RNA interference.[2]

miR-150 functions in hematopoiesis; it regulates genes whose downstream products encourage differentiating stem cells towards becoming megakaryocytes rather than erythrocytes.[3] [4] It is also thought to control B and T cell differentiation, alongside miR-155.[5] [6]

Role in cancer

miR-150 has been linked with a number of cancers. It is thought to promote cancer cell proliferation in gastric cancer and has also been found to be more than 50x overexpressed in osteosarcoma.[7]

Applications

miR-150 levels in blood plasma can be indicative of early sepsis; it could have a future use therapeutically in treating the condition.[8] In addition, miR-150 is one of a number of microRNAs whose expression profile could be used as a biomarker of hepatocellular carcinoma.[9]

Further reading

Notes and References

  1. Ambros V . microRNAs: tiny regulators with great potential . Cell . 107 . 7 . 823–6 . Dec 2001 . 11779458 . 10.1016/S0092-8674(01)00616-X . 14574186 . free .
  2. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R . Human RISC couples microRNA biogenesis and posttranscriptional gene silencing . Cell . 123 . 4 . 631–40 . Nov 2005 . 16271387 . 10.1016/j.cell.2005.10.022 . 16973870 . free .
  3. Lu J, Guo S, Ebert BL, Zhang H, Peng X, Bosco J, Pretz J, Schlanger R, Wang JY, Mak RH, Dombkowski DM, Preffer FI, Scadden DT, Golub TR . MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors . Developmental Cell . 14 . 6 . 843–53 . Jun 2008 . 18539114 . 2688789 . 10.1016/j.devcel.2008.03.012 .
  4. Edelstein LC, Bray PF . MicroRNAs in platelet production and activation . Blood . 117 . 20 . 5289–96 . May 2011 . 21364189 . 3109704 . 10.1182/blood-2011-01-292011 .
  5. Vasilatou D, Papageorgiou S, Pappa V, Papageorgiou E, Dervenoulas J . The role of microRNAs in normal and malignant hematopoiesis . European Journal of Haematology . 84 . 1 . 1–16 . Jan 2010 . 19744129 . 10.1111/j.1600-0609.2009.01348.x . 46395419 . free .
  6. Garzon R, Croce CM . MicroRNAs in normal and malignant hematopoiesis . Current Opinion in Hematology . 15 . 4 . 352–8 . Jul 2008 . 18536574 . 10.1097/MOH.0b013e328303e15d . 12931709 .
  7. Lulla RR, Costa FF, Bischof JM, Chou PM, Bonaldo MF, Vanin EF, Soares MB . Identification of Differentially Expressed MicroRNAs in Osteosarcoma . Sarcoma . 2011 . 732690 . 2011 . 21789031 . 3140035 . 10.1155/2011/732690 . free .
  8. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, Nicoloso MS, Barbarotto E, Popa M, Stanciulea O, Fernandez MH, Tulbure D, Bueso-Ramos CE, Negrini M, Calin GA . MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis . PLOS ONE . 4 . 10 . e7405 . 2009-10-12 . 19823581 . 2756627 . 10.1371/journal.pone.0007405 . 2009PLoSO...4.7405V . Gold . Jeffrey A . free .
  9. Magrelli A, Azzalin G, Salvatore M, Viganotti M, Tosto F, Colombo T, Devito R, Di Masi A, Antoccia A, Lorenzetti S, Maranghi F, Mantovani A, Tanzarella C, Macino G, Taruscio D . Altered microRNA Expression Patterns in Hepatoblastoma Patients . Translational Oncology . 2 . 3 . 157–63 . Aug 2009 . 19701500 . 2730135 . 10.1593/tlo.09124.